News
A panelist explains how the distinct mechanisms of erythropoiesis-stimulating agents (ESAs), luspatercept, and imetelstat ...
Anita Turk, MD, discusses the unmet needs that still exist in the realm of colorectal cancer treatment and management.
1d
News-Medical.Net on MSNReversing immune fatigue offers new hope for cancer treatmentCD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...
10h
AZoLifeSciences on MSNReinvigorating T Cells Offers Hope for More Effective Cancer ImmunotherapyCD8⁺ T cells are the immune system's frontline warriors, charged with detecting and eliminating cancer cells. But in the ...
Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Immuno-oncology Market offers comprehensive insights into the market landscape, customer ...
Liver injuries also prompted the FDA to impose a partial clinical hold on Sanofi's BTK inhibitor tolebrutinib (SAR442168) earlier this year, holding up a programme that was a key part of its $3.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results